Rapport Therapeutics, Inc. (RAPP) — 8-K Filings
All 8-K filings from Rapport Therapeutics, Inc.. Browse 8 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (8)
- 8-K Filing — May 7, 2026
-
Rapport Therapeutics Enters Material Definitive Agreement
— Sep 10, 2025 Risk: medium
On September 9, 2025, Rapport Therapeutics, Inc. entered into a material definitive agreement. The filing does not disclose specific details of the agreement or -
Rapport Therapeutics Files 8-K
— Sep 8, 2025 Risk: low
On September 8, 2025, Rapport Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure, Other Events, and Financial Statem -
Rapport Therapeutics Files 8-K on Shareholder Vote Matters
— Jun 18, 2025 Risk: low
Rapport Therapeutics, Inc. filed an 8-K on June 18, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 17, 2025. The - 8-K Filing — Jun 2, 2025
- 8-K Filing — Mar 3, 2025
-
Roivant Sciences to Acquire Rapport Therapeutics for $180M
— Jan 10, 2025 Risk: medium
Rapport Therapeutics, Inc. announced on January 9, 2025, that it has entered into a definitive agreement to be acquired by an affiliate of Roivant Sciences. The -
Rapport Therapeutics Files 8-K: Agreements & Equity
— Jun 10, 2024 Risk: medium
On June 6, 2024, Rapport Therapeutics, Inc. entered into a material definitive agreement related to its business operations. The company also reported on unregi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX